altherapharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.altherapharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Heart Health | Althera
Description Althera Pharmaceuticals, a company focused on heart health, announces FDA approval of Roszet (rosuvastatin and ezetimibe) tablets. Founded in 2010, Althera develops innovative patient focused medicines to improve cardiovascular
Keywords N/A
Server Information
WebSite altherapharma faviconaltherapharma.com
Host IP 185.230.63.186
Location -
Related Websites
Site Rank
More to Explore
altherapharma.com Valuation
US$5,910,840
Last updated: 2023-05-17 06:27:41

altherapharma.com has Semrush global rank of 1,790,660. altherapharma.com has an estimated worth of US$ 5,910,840, based on its estimated Ads revenue. altherapharma.com receives approximately 682,020 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, altherapharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$5,910,840
Daily Ads Revenue US$5,457
Monthly Ads Revenue US$163,685
Yearly Ads Revenue US$1,964,218
Daily Unique Visitors 45,468
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
altherapharma.com. A 3600 IP: 185.230.63.186
altherapharma.com. A 3600 IP: 185.230.63.171
altherapharma.com. A 3600 IP: 185.230.63.107
altherapharma.com. NS 86400 NS Record: ns3.wixdns.net.
altherapharma.com. NS 86400 NS Record: ns2.wixdns.net.
HtmlToTextCheckTime:2023-05-17 06:27:41
top of page Home About Althera Values Leadership Team Careers Pipeline Products Contact Us Partnerships Focused on Your Health ​ Founded in 2010, Althera develops innovative patient focused medicines. ​ Althera’s Rosuvastatin/Ezetimibe tablets is already approved and available to patients in more than 28 countries worldwide including United States and all major European markets. ​ US Healthcare Professionals can learn more about Roszet® at www.roszet.com . Please read full Prescribing information at roszet.com/pi . ​ Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients next year. © Copyright Althera Pharmaceuticals . bottom of
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 10 Mar 2022 09:00:25 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.altherapharma.com/
strict-transport-security: max-age=3600
Age: 71423
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: yKskFaTI/RmB0yGOaMOo6Q==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVg9YO3V+fCFzk4JPgdRWZWy,m0j2EEknGIVUW/liY8BLLletGEKvLVzie0xVdA3MK9EFJmEKNgQ96+wiTVoMq713,2d58ifebGbosy5xc+FRalupVI2j5UAfKbrZf1zLWYq3pNht8xyRbv8TThIH1DWZ4xwyNmCajEja0C5E/c2QhCQ==,2UNV7KOq4oGjA5+PKsX47MrVZEzBMcoq97TK4HZFAZG8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1646902825.12136833276041771
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 10 Mar 2022 09:00:25 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1646902825.32862029151332444
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMfPzr8YiYB1ApTEn2w/dWFA,qquldgcFrj2n046g4RNSVBKUaXHrucSLmP/C0nqrtU9YgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalg4Zn98z+QlrPEWVqrYj4zY7TIzqr9Bk8VnOEJ2JvMQD3QpI/ucnHvfrUjeESIoVekFCwajok/OCgygtFhNr4vg=,2UNV7KOq4oGjA5+PKsX47IVh8rwr1kfSZp8MOIif7faa46R9xNIlpQ4eUPYpBuqs,2r0eby5dl6V4RsTzy6fSQIwoQGSqOdRbzD/bJEHbtbN9pAiCxHhredE3m8SaSeMp,w4q8mm9FnmU4emOs6psVXYiCXMd+9HUrVaHbRGVCtGJNG+KuK+VIZfbNzHJu0vJu,4EmzKGKKpFffqfFwZRPY8fVE+EAXpHFvSHILObqXykiDRQsO3Z3dkEVzOZlaC0stWIHlCalF7YnfvOr2cMPpyw==,w4q8mm9FnmU4emOs6psVXYiCXMd+9HUrVaHbRGVCtGJNG+KuK+VIZfbNzHJu0vJu,l7Ey5khejq81S7sxGe5Nk8R9id1Yuu5BYunuLSRGBktNG+KuK+VIZfbNzHJu0vJu,LoUK8/saGAmOxZWtpubo2hCTZIovVLWxYnpvwA85+h4nxPu6u+7opwZSMME6PJ8aIccbxmNPqjEs+7YR4gg4qQ==,l7Ey5khejq81S7sxGe5Nk8R9id1Yuu5BYunuLSRGBktNG+KuK+VIZfbNzHJu0vJu,Ts+7R/4FijtA6c9psi3FQMTEHTpQB0YpAuTRJdqreaeTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,/a5ccLSK1HEmwPNg/x6Ouu8iFThDVKqDvu3WjIYEkdqsnTWn1WTumsFiNVkYI1OFIHeCiaoOFQyA49r8B0Rrpg==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Thu, 10 Mar 2022 09:00:45 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
altherapharma.com Whois Information
Domain Name: ALTHERAPHARMA.COM
Registry Domain ID: 2010643735_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-02-10T10:19:05Z
Creation Date: 2016-03-09T15:18:40Z
Registry Expiry Date: 2023-02-09T11:59:59Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-10T09:26:53Z <<<

Copyright © 2022 WebZZ.US 0.0224